Combined Renin Inhibition/Beta-blockade

NCT00627861 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped The renin laboratory used in the study is no longer available.

Conditions

Hypertension

Interventions

DRUG: Aliskiren
DRUG: Extended-release metoprolol

Sponsor

The Rogosin Institute